Component

Cure rate and egg reduction rate in treated infection

Cure rate and egg reduction rate in treated infection. Species, exposure and limitations are retained in each linked claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. In 958 children randomly allocated to seven treatment groups, the efficacy of single-dose 300 milligrams of polymorph A was not different from the placebo control at the 0.05 level in both hookworm and Trichuris infections, while the egg reduction and cure rates of 300 and 500 milligrams of polymorph C were similar to each other though inferior to the standard 100 milligrams twice daily for three days.

    Experimental context and source evidence
    availability_state
    biomarker_context Imported condition classification; unverified.
    evidence_span
    {"source_cache": "artifacts/mebendazole-research/7939946.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "972b8bb36b68b1f40fba5f7bdb38668e9d1c40cba27ddeb19db16a3bcf29053d", "start_char": 0, "end_char": 698, "text_sha256": "972b8bb36b68b1f40fba5f7bdb38668e9d1c40cba27ddeb19db16a3bcf29053d"}
    experimental_model
    Randomised seven-arm trial in 958 schoolchildren in Southern Thailand
    exposure
    Single doses of 300 milligrams polymorph A, 300 and 500 milligrams polymorph C, against placebo and against 100 milligrams polymorph C twice daily for three days
    limitations
    The only human record here that varies the crystal form, with a placebo arm. It is a single-dose comparison and does not follow reinfection.
    nutrient_topic
    Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms. · Mebendazole
    organism
    Human
    plain_language
    In children, a full dose of the wrong crystal form worked no better than a sugar pill.
    primary_references
    [mbz-p7939946] Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections. (1993). https://pubmed.ncbi.nlm.nih.gov/7939946/
    tissue_or_cell_type
    Hookworm and Trichuris infection
    trigger_kind
    biomarker_context Imported condition classification; unverified.

    Mebendazole: the tubulin it binds, why that is selective, the crystal form that decides whether any of it works, and the off-target that became an oncology programme (2026-09-22) · lines 368–379

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomised seven-arm trial in 958 schoolchildren in Southern Thailand · source_derived_draft · unverified_draft

    ### mbz-polymorph-a-equals-placebo In 958 children randomly allocated to seven treatment groups, the efficacy of single-dose 300 milligrams of polymorph A was not different from the placebo control at the 0.05 level in both hookworm and Trichuris infections, while the egg reduction and cure rates of 300 and 500 milligrams of polymorph C were similar to each other though inferior to the standard 100 milligrams twice daily for three days. Condition category: biomarker_context nutrient_topic: Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms. plain_language: In children, a full dose of the wrong crystal form worked no better than a sugar pill. organism: Human tissue_or_cell_type: Hookworm and Trichuris infection experimental_model: Randomised seven-arm trial in 958 schoolchildren in Southern Thailand limitations: The only human record here that varies the crystal form, with a placebo arm. It is a single-dose comparison and does not follow reinfection. exposure: Single doses of 300 milligrams polymorph A, 300 and 500 milligrams polymorph C, against placebo and against 100 milligrams polymorph C twice daily for three days evidence_span: {"source_cache": "artifacts/mebendazole-research/7939946.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "972b8bb36b68b1f40fba5f7bdb38668e9d1c40cba27ddeb19db16a3bcf29053d", "start_char": 0, "end_char": 698, "text_sha256": "972b8bb36b68b1f40fba5f7bdb38668e9d1c40cba27ddeb19db16a3bcf29053d"} [mbz-p7939946] Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections. (1993). https://pubmed.ncbi.nlm.nih.gov/7939946/
    Complete structured claim and evidence
  2. Testing the biological activity of the three polymorphic forms of mebendazole called A, B and C by median lethal dose in mice after oral and intraperitoneal administration and by anthelmintic effect against the enteral and parenteral phases of Trichinella spiralis, the polymorphic form A was the least toxic and the least effective, and use of polymorph C was judged advisable for oral treatment given its lower toxicity than form B and similar anthelmintic effect.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/mebendazole-research/3608627.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cf4b94d7b266abf376ded706272be7f440f6f46b82db5ee9c36d2c34af6e8825", "start_char": 0, "end_char": 608, "text_sha256": "cf4b94d7b266abf376ded706272be7f440f6f46b82db5ee9c36d2c34af6e8825"}
    experimental_model
    Median lethal dose and anthelmintic efficacy of three mebendazole polymorphs in mice
    exposure
    Polymorphs A, B and C given orally and intraperitoneally, against enteral and parenteral phases of infection
    limitations
    Tests toxicity and efficacy of the three solid forms in the same animals. Numerical values for the median lethal doses are not given in the abstract and are not assumed here.
    nutrient_topic
    Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms. · Mebendazole
    organism
    Mouse
    plain_language
    One crystal form of the same molecule barely poisons the mouse and barely touches the worm.
    primary_references
    [mbz-p3608627] Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms. (1987). https://pubmed.ncbi.nlm.nih.gov/3608627/ DOI: 10.1159/000238506
    tissue_or_cell_type
    Whole body and Trichinella spiralis infection

    Mebendazole: the tubulin it binds, why that is selective, the crystal form that decides whether any of it works, and the off-target that became an oncology programme (2026-09-22) · lines 355–366

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Median lethal dose and anthelmintic efficacy of three mebendazole polymorphs in mice · source_derived_draft · unverified_draft

    ### mbz-polymorph-a-is-inert Testing the biological activity of the three polymorphic forms of mebendazole called A, B and C by median lethal dose in mice after oral and intraperitoneal administration and by anthelmintic effect against the enteral and parenteral phases of Trichinella spiralis, the polymorphic form A was the least toxic and the least effective, and use of polymorph C was judged advisable for oral treatment given its lower toxicity than form B and similar anthelmintic effect. Condition category: normal nutrient_topic: Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms. plain_language: One crystal form of the same molecule barely poisons the mouse and barely touches the worm. organism: Mouse tissue_or_cell_type: Whole body and Trichinella spiralis infection experimental_model: Median lethal dose and anthelmintic efficacy of three mebendazole polymorphs in mice limitations: Tests toxicity and efficacy of the three solid forms in the same animals. Numerical values for the median lethal doses are not given in the abstract and are not assumed here. exposure: Polymorphs A, B and C given orally and intraperitoneally, against enteral and parenteral phases of infection evidence_span: {"source_cache": "artifacts/mebendazole-research/3608627.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cf4b94d7b266abf376ded706272be7f440f6f46b82db5ee9c36d2c34af6e8825", "start_char": 0, "end_char": 608, "text_sha256": "cf4b94d7b266abf376ded706272be7f440f6f46b82db5ee9c36d2c34af6e8825"} [mbz-p3608627] Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms. (1987). https://pubmed.ncbi.nlm.nih.gov/3608627/ DOI: 10.1159/000238506
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards